Patent Application
20180346648
Nano- or micro-encapsulation is used in a variety of different applications where there is a need to deliver, apply, or release a fragrance or other active materials in a time-delayed or controlled manner.
Aminoplast and polyurea microcapsules have been developed to provide good performance in laundry applications. See U.S. Pat. No. 6,261,483, US 2014/0287008, and WO 2015/023961. Preparation of an aminoplast microcapsule involves use of undesirable formaldehyde. A polyurea microcapsule is typically prepared from a polyisocyanate. Unreacted formaldehyde and polyisocyanate inevitably remain in the final product. Due to regulatory and environmental concerns, it is desirable to reduce or avoid the use of both formaldehyde and the polyisocyanate.
In an effort to eliminate the use of formaldehyde, U.S. Pat. No. 8,835,002 and US 2014/0322283 describe a microcapsule essentially free of formaldehyde prepared from melamine. However, its performance or stability is problematic in certain applications.
There is a need to develop a microcapsule with high performance and stability for delivering and releasing a fragrance, flavor, or cosmetic active in a controlled manner.
This invention is based on the discovery that branched polyethyleneimine (“BPEI”) microcapsules show high performance and great stability.
Accordingly, one aspect of this invention relates to a BPEI microcapsule containing an oil core and a microcapsule wall encapsulating the oil core.
The oil core contains an active material, such as a fragrance, pro-fragrance, flavor, vitamin or derivative thereof, malodor counteractive agent, anti-inflammatory agent, fungicide, anesthetic, analgesic, antimicrobial active, anti-viral agent, anti-infectious agent, anti-acne agent, skin lightening agent, insect repellant, emollient, skin moisturizing agent, wrinkle control agent, UV protection agent, fabric softener active, hard surface cleaning active, skin or hair conditioning agent, insect repellant, animal repellent, vermin repellent, flame retardant, antistatic agent, nanometer to micron size inorganic solid, polymeric or elastomeric particle, and combinations thereof.
The microcapsule wall is formed of an encapsulating polymer that is a reaction product of (i) a branched polyethyleneimine (“BPEI”), a mixture of the branched polyethyleneimine and a polyfunctional amine, or a mixture of the branched polyethyleneimine and a polyfunctional alcohol, and (ii) a carbonyl crosslinker, or a mixture of a carbonyl crosslinker and a polyisocyanate. The carbonyl crosslinker has a first functional group and a second functional group, both of which are reactive towards the branched polyethyleneimine, the polyfunctional amine, or the polyfunctional alcohol.
The BPEI typically has a molecular weight of 500 to 5,000,000 Daltons (e.g., 600 to 2,000,000 Daltons, 700 to 1,000,000 Daltons, 750 to 200,000, preferably 750 to 50,000 Daltons). The molar ratio between the BPEI and the carbonyl crosslinker is 1:100 to 100:1 (e.g., 1:50 to 50:1, preferably 1:20 to 20:1, and more preferably 1:10 to 1:1).
The carbonyl crosslinker can have a molecular weight of 30 to 5,000,000 Daltons (e.g., 50 to 10,000 Daltons, 50 to 5,000 Daltons, 50 to 2,500 Daltons, and 55 to 2,000 Daltons).
In the carbonyl crosslinker, the first functional group is a first electrophilic group, preferably, a carbonyl electrophilic group. Examples of a carbonyl electrophilic group include formyl, keto, carboxyl, a carboxylate ester group, an acyl halide group, an amide group, and a carboxylic anhydride group. Other suitable electrophilic groups include an alkyl halide group, an epoxide group, an aziridine group, an oxetane group, an azetidine group, a sulfonyl halide group, a chlorophosphate group, an α,β-unsaturated carbonyl group, an α,β-unsaturated nitrile group, an α,β-unsaturated methanesulfonyl group, a trifluoromethanesulfonate group, and a p-toluenesulfonate group. Preferred groups are formyl, acyl halide groups, and carboxylic anhydride groups.
The second functional group is a second electrophilic group, e.g., formyl, keto, carboxyl, a carboxylate ester group, an acyl halide group, an amide group, a carboxylic anhydride group, an alkyl halide group, an epoxide group, an aziridine group, an oxetane group, an azetidine group, a sulfonyl halide group, a chlorophosphate group, an isocyanate group, an α,β-unsaturated carbonyl group, an α,β-unsaturated nitrile group, an α,β-unsaturated methanesulfonyl group, a trifluoromethanesulfonate group, or a p-toluenesulfonate group. In some embodiments, at least one of the first and second functional group contains a carbonyl electrophilic group.
In some embodiments, the carbonyl crosslinker has at least two formyl groups. Examples include dialdehydes such as glyoxal, malonaldehyde (propanedial), succinaldehyde (butanedial), glutaraldehyde (pentanedial), adipaldehyde (hexanedial), starch aldehyde, and combinations thereof. Formaldehyde is also a suitable carbonyl crosslinker useful in preparing a microcapsule of this invention.
In one embodiment, the microcapsule wall is formed of an encapsulating polymer that is the reaction product of (i) the branched polyethyleneimine and (ii) the carbonyl crosslinker.
In another embodiment, the microcapsule wall is formed of an encapsulating polymer that is the reaction product of (i) the branched polyethyleneimine and (ii) the mixture of the carbonyl crosslinker and the polyisocyanate.
Another aspect of this invention relates to a microcapsule containing an oil core and a microcapsule wall encapsulating the oil core, in which the oil core contains an active material and the microcapsule wall is formed of an aggregate of a branched polyethyleneimine.
The aggregate of the branched polyethyleneimine can further contain, at a level of 0.1 to 20% (e.g., 1 to 10%, 2 to 8%, and 3 to 5%) by weight of the microcapsule, an anionic polymer selected from the group consisting of an alginate, poly(styrene sulfonate), hyaluronic acid, poly(acrylic acid), carboxymethyl cellulose, gelatin, and combinations thereof. The weight ratio between the branched polyethyleneimine and the anionic polymer is 10:1 to 1:10 (e.g., 5:1 to 1:5 and 2:1 to 1:2).
In some embodiments, the microcapsule wall has a layer-by-layer structure. For a method of preparing the layer-by-layer structure, see Tong et al., Colloid Polym Sci 286, 1103-09 (2008).
Any of the aggregates described above can further contain a water-soluble cation, a water-soluble anion, or a transglutaminase.
In any of the microcapsules described above, a deposition aid can also be included. Nonlimiting examples of the deposition aid are polyquaternium-4, polyquaternium-5, polyquaternium-6, polyquaternium-7, polyquaternium-10, polyquaternium-16, polyquaternium-22, polyquaternium-24, polyquaternium-28, polyquaternium-39, polyquaternium-44, polyquaternium-46, polyquaternium-47, polyquaternium-53, polyquaternium-55, polyquaternium-67, polyquaternium-68, polyquaternium-69, polyquaternium-73, polyquaternium-74, polyquaternium-77, polyquaternium-78, polyquaternium-79, polyquaternium-80, polyquaternium-81, polyquaternium-82, polyquaternium-86, polyquaternium-88, polyquaternium-101, polyvinylamine, polyethyleneimine, polyvinylamine and vinylformamide copolymer, and any combinations thereof.
A third aspect of this invention relates to a method of preparing a microcapsule formed of an aggregate of a branched polyethyleneimine. The method includes the steps of: (a) providing an oil-in-water emulsion that contains the following: (i) a branched polyethyleneimine, (ii) an oil phase having an active material, and (iii) an aqueous phase having a microcapsule formation aid and water; (b) causing the formation of a microcapsule precursor having an oil core that contains the active material and a microcapsule wall formed of an aggregate of the branched polyethyleneimine; and (c) curing the microcapsule precursor to obtain a microcapsule slurry that contains the microcapsule formed of the aggregate of the branched polyethyleneimine.
Formation of the aggregate can be achieved by (i) adding an anionic polymer, a water-soluble cation, a water-soluble anion, transglutaminase, or any combination thereof, (ii) adjusting the pH of the oil-in-water emulsion, or (iii) both of (i) and (ii).
As such, in one embodiment, the oil-in-water emulsion further contains an anionic polymer selected from the group consisting of an alginate, poly(styrene sulfonate), hyaluronic acid, casein, poly(acrylic acid), carboxymethyl cellulose, and combinations thereof. In another embodiment, the oil-in-water emulsion further contains a water-soluble cation, a water-soluble anion, or transglutaminase.
Also within the scope of this invention is a microcapsule composition containing one of the above-described microcapsules, together with a microcapsule formation aid and/or a deposition aid.
Still within the scope of this invention is a method of preparing a microcapsule having an encapsulating polymer formed of a branched polyethyleneimine and a carbonyl crosslinker. The method include the steps of: (a) providing an oil-in-water emulsion containing (i) the branched polyethyleneimine, a mixture of the branched polyethyleneimine and a polyfunctional amine, or a mixture of the branched polyethyleneimine and a polyfunctional alcohol, (ii) the carbonyl crosslinker, or a mixture of the carbonyl crosslinker and a polyisocyanate, (iii) an oil phase having an active material, and (iv) an aqueous phase having a microcapsule formation aid and water; (b) causing the formation of a microcapsule precursor having an oil core that contains the active material and a microcapsule wall that is formed of the network of an amide polymer; and (c) curing the microcapsule precursor to obtain a microcapsule slurry that contains the microcapsule having an encapsulating polymer formed of the branched polyethyleneimine and the carbonyl crosslinker. The active material and the carbonyl crosslinker have been described above.
This method can further include the step of adding transglutaminase to the oil-in-water emulsion, and/or adding a reducing agent (e.g., sodium borohydride) to the microcapsule slurry.
In any of the methods described above, the microcapsule precursor is typically cured at a temperature of 20 to 250° C. (e.g., 35 to 145° C.); and/or the microcapsule formation aid is preferably selected from the group consisting of polyvinyl pyrrolidone, polyvinyl alcohol, poly(styrene sulfonate), carboxymethyl cellulose, sodium salt of naphthalene sulfonate condensate, co-polymer of ethylene and maleic anhydride, an alginate, hyaluronic acid, poly(acrylic acid), carboxymethyl cellulose, copolymers of acrylic acid and acrylamide, copolymers of acrylamide and acrylamidopropyltrimonium chloride, terpolymers of acrylic acid, acrylamide, and acrylamidopropyltrimonium chloride, partially or completely hydrolyzed polyvinyl acetate polymers (i.e., polyvinyl alcohols), and combinations thereof.
Any of these methods can further include either or any combination of the following step: (i) adding a deposition aid to the microcapsule slurry, (ii) washing the microcapsule slurry with water, (iii) spray drying the microcapsule slurry to obtain the microcapsule in a powder form.
Still yet within the scope of this invention are consumer products containing any of the microcapsules described above. The consumer products include hair care products such as shampoos and hair conditioners, personal care products for example bar soaps, fabric care products include detergents, fabric conditioners, fabric refresher and the like, and home care products.
All parts, percentages and proportions refer to herein and in the claims are by weight unless otherwise indicated.
The values and dimensions disclosed herein are not to be understood as being strictly limited to the exact numerical values recited. Instead, unless otherwise specified, each such value is intended to mean both the recited value and a functionally equivalent range surrounding that value. For example, a value disclosed as “50%” is intended to mean “about 50%.”
The terms “capsule” and “microcapsule” herein are used interchangeably.
The terms “polyfunctional isocyanate,” “multifunctional isocyanate,” and “polyisocyanate” all refer to a compound having two or more isocyanate (—NCO) groups.
The terms “polyfunctional amine,” “multifunctional amine,” and “polyamine” refers to a compound containing two or more primary or secondary amine groups. These terms also refers to a compound containing one or more primary/secondary amine groups and one or more hydroxyl groups (—OH).
The terms “polyfunctional alcohol,” “multifunctional alcohol,” “poly alcohol,” and “polyol” refer to a compound having two or more hydroxyl groups.
The term “carbonyl electrophile” refers to a chemical moiety having a carbonyl group that is attracted to an electron rich center and is capable of receiving a pair of electrons to make a new covalent bond.
The term “carbonyl” refers to —C(O)—. Examples include formyl, keto, carboxyl, carboxylate ester, acyl halide, amide, and carboxylic anhydride.
The term “formyl” refers to —C(O)H connecting to an aliphatic, heteroaliphatic, aryl, or heteroaryl group.
The term “keto” refers to —C(O)— connecting to an aliphatic, heteroaliphatic, aryl, or heteroaryl group.
The term “carboxyl” refers to —C(O)OH or —C(O)O− connecting to an aliphatic, heteroaliphatic, aryl, or heteroaryl group.
The term “carboxylate ester” refers to —C(O)ORa connecting to an aliphatic, heteroaliphatic, aryl, or heteroaryl group, in which Ra is an aliphatic, heteroaliphatic, aryl, or heteroaryl group.
The term “acyl halide” refers to —C(O)X connecting to an aliphatic, heteroaliphatic, aryl, or heteroaryl group, in which X is F, Cl, Br, or I, preferably Cl or Br.
The term “amide” refers to —C(O)NRbRc connecting to an aliphatic, heteroaliphatic, aryl, or heteroaryl group, in which each of Rb and Rc, independently, is an aliphatic, heteroaliphatic, aryl, or heteroaryl group.
The term “carboxylic anhydride” refers to —C(O)OC(O)— connecting to two aliphatic, heteroaliphatic, aryl, or heteroaryl groups.
The term “alkyl halide” refers to —RdX, in which Rd is alkyl and X is F, Cl, Br, or I (preferably Cl or Br).
The term “epoxide” refers to a three-membered ring formed of two carbon atoms and an oxygen atom.
The term “aziridine” refers to a three-membered ring formed of two carbon atoms and a nitrogen atom.
The term “oxetane” refers to a four-membered ring formed of three carbon atoms and an oxygen atom.
The term “azetidine” refers to a four-membered ring formed of three carbon atoms and a nitrogen atom.
The term “sulfonyl halide” refers to —SO2X connecting to an aliphatic, heteroaliphatic, aryl, or heteroaryl group, in which X is F, Cl, Br, or I (preferably Cl or Br).
The term “chlorophosphate” refers to —OP(O)(Cl)O— connecting to two aliphatic, heteroaliphatic, aryl, or heteroaryl groups.
The term “isocyanate” refers to —NCO connecting to an aliphatic, heteroaliphatic, aryl, or heteroaryl group.
The term “α,β-unsaturated carbonyl” refers to —CRc═CRf—C(O)—, in which CRe connects to an aliphatic, heteroaliphatic, aryl, or heteroaryl group; C(O)— connects to H, aliphatic, heteroaliphatic, aryl, heteroaryl, alkoxy, or amino; and each of Re and Rf, independently, is aliphatic, heteroaliphatic, aryl, or heteroaryl.
The term “α,β-unsaturated nitrile” refers to —CRg═CRh—CN, in which CRg connects to an aliphatic, heteroaliphatic, aryl, or heteroaryl group; and each of Rg and Rh, independently, is aliphatic, heteroaliphatic, aryl, or heteroaryl.
The term “α,β-unsaturated methanesulfonyl” refers to —CRi═CRj—SO2CH3 connecting to an aliphatic, heteroaliphatic, aryl, or heteroaryl group.
The term “aliphatic” herein refers to a saturated or unsaturated, linear or branched, acyclic, cyclic, or polycyclic hydrocarbon moiety. Examples include, but are not limited to, alkyl, alkylene, alkenyl, alkenylene, alkynyl, alkynylene, cycloalkyl, cycloalkylene, cycloalkenyl, cycloalkylene, cycloalkynyl, and cycloalkynylene moieties. The term “alkyl” or “alkylene” refers to a saturated, linear or branched hydrocarbon moiety, such as methyl, methylene, ethyl, ethylene, propyl, propylene, butyl, butylene, pentyl, pentylene, hexyl, hexylene, heptyl, heptylene, octyl, octylene, nonyl, nonylene, decyl, decylene, undecyl, undecylene, dodecyl, dodecylene, tridecyl, tridecylene, tetradecyl, tetradecylene, pentadecyl, pentadecylene, hexadecyl, hexadecylene, heptadecyl, heptadecylene, octadecyl, octadecylene, nonadecyl, nonadecylene, icosyl, icosylene, triacontyl, and triacontylene. The term “alkenyl” or “alkenylene” refers to a linear or branched hydrocarbon moiety that contains at least one double bond, such as —CH═CH—CH3 and —CH═CH—CH2—. The term “alkynyl” or “alkynylene” refers to a linear or branched hydrocarbon moiety that contains at least one triple bond, such as —C≡C—CH3 and —C≡C—CH2—. The term “cycloalkyl” or “cycloalkylene” refers to a saturated, cyclic hydrocarbon moiety, such as cyclohexyl and cyclohexylene. The term “cycloalkenyl” or “cycloalkenylene” refers to a non-aromatic, cyclic hydrocarbon moiety that contains at least one double bond, such as cyclohexenyl and cyclohexenylene. The term “cycloalkynyl” or “cycloalkynylene” refers to a non-aromatic, cyclic hydrocarbon moiety that contains at least one triple bond, cyclooctynyl and cyclooctynylene.
The term “heteroaliphatic” herein refers to an aliphatic moiety containing at least one heteroatom selected from N, O, P, B, S, Si, Sb, Al, Sn, As, Se, and Ge.
The term “aryl” herein refers to a C6 monocyclic, C10 bicyclic, C14 tricyclic, C20 tetracyclic, or C24 pentacyclic aromatic ring system. Examples of aryl groups include, but are not limited to, phenyl, phenylene, naphthyl, naphthylene, anthracenyl, anthracenylene, pyrenyl, and pyrenylene. The term “heteroaryl” herein refers to an aromatic 5-8 membered monocyclic, 8-12 membered bicyclic, 11-14 membered tricyclic, and 15-20 membered tetracyclic ring system having one or more heteroatoms (such as O, N, S, or Se). Examples of heteroaryl groups include, but are not limited to, furyl, furylene, fluorenyl, fluorenylene, pyrrolyl, pyrrolylene, thienyl, thienylene, oxazolyl, oxazolylene, imidazolyl, imidazolylene, benzimidazolyl, benzimidazolylene, thiazolyl, thiazolylene, pyridyl, pyridylene, pyrimidinyl, pyrimidinylene, quinazolinyl, quinazolinylene, quinolinyl, quinolinylene, isoquinolyl, isoquinolylene, indolyl, and indolylene.
Unless specified otherwise, aliphatic, heteroaliphatic, oxyaliphatic, alkyl, alkylene, alkenyl, alkenylene, alkynyl, alkynylene, cycloalkyl, cycloalkylene, cycloalkenyl, cycloalkenylene, cycloalkynyl, cycloalkynylene, heterocycloalkyl, heterocycloalkylene, heterocycloalkenyl, heterocycloalkenylene, aryl, and heteroaryl mentioned herein include both substituted and unsubstituted moieties. Possible substituents on cycloalkyl, cycloalkylene, cycloalkenyl, cycloalkenylene, cycloalkynyl, cycloalkynylene, heterocycloalkyl, heterocycloalkylene, heterocycloalkenyl, heterocycloalkenylene, aryl, and heteroaryl include, but are not limited to, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, C3-C20 cycloalkyl, C3-C20 cycloalkenyl, C3-C20 heterocycloalkyl, C3-C20 heterocycloalkenyl, C1-C10 alkoxy, aryl, aryloxy, heteroaryl, heteroaryloxy, amino, C1-C10 alkylamino, C2-C20 dialkylamino, arylamino, diarylamino, C1-C10 alkylsulfonamino, arylsulfonamino, C1-C10 alkylimino, arylimino, C1-C10 alkylsulfonimino, arylsulfonimino, hydroxyl, halo, thio, C1-C10 alkylthio, arylthio, C1-C10 alkylsulfonyl, arylsulfonyl, acylamino, aminoacyl, aminothioacyl, amido, amidino, guanidine, ureido, thioureido, cyano, nitro, nitroso, azido, acyl, thioacyl, acyloxy, carboxyl, and carboxylic ester. On the other hand, possible substituents on aliphatic, heteroaliphatic, oxyaliphatic, alkyl, alkylene, alkenyl, alkenylene, alkynyl, and alkynylene include all of the above-recited substituents except C1-C10 alkyl. Cycloalkyl, cycloalkylene, cycloalkenyl, cycloalkenylene, heterocycloalkyl, heterocycloalkylene, heterocycloalkenyl, heterocycloalkenylene, aryl, and heteroaryl can also be fused with each other.
The details of one or more embodiments of the invention are set forth in the description below. Other features, objects, and advantages will be apparent from the description and the claims.
It has been found that BPEI microcapsules are suitable for delivering active materials such as fragrances in consumer products.
These BPEI microcapsules find their utility in a wide range of consumer applications, e.g., personal care products including shampoos, hair conditioners, hair rinses, hair refreshers; personal wash such as bar soaps, body wash, personal cleaners and sanitizers, hydro-alcoholic formulations; fabric care such as fabric refreshers, softeners and dryer sheets, ironing water, industrial cleaners, liquid and powder detergent including unit dose capsules, rinse conditioners, and scent booster products; fine fragrances; an Eau De Toilette products; deodorants; roll-on products, and aerosol products.
The BPEI microcapsules preferably have a size in the range of from 0.01 to 1000 microns in diameter (e.g., 0.5 to 1000 microns, 1 to 200 microns, 0.5 to 150 microns, 0.1 to 100 microns, 2 to 50 microns, 5 to 25 microns, 2 to 15 microns, and 1 to 10 microns). The capsule distribution can be narrow, broad, or multi-modal.
The BPEI microcapsules of this invention each include an oil core and a capsule wall encapsulating the oil core.
The oil core contains an active material, which is preferably a fragrance, flavor, malodor counteractive agent, a cosmetic active, or a combination thereof. The active material can be present at a level of 5 to 95% (preferably 20 to 90% and more preferably 40 to 85%) by weight of the microcapsule.
In one aspect, the microcapsule wall is formed of an encapsulating polymer that is a reaction product of a BPEI and a carbonyl crosslinker.
The BPEI can be used free of any other polyamine or polyalcohol. It can also be used together with one or more polyamines and/or polyalcohols.
The carbonyl crosslinker can be used by itself. It can also be used together with one or more polyisocyanates and/or one or more other carbonyl crosslinker.
In another aspect, the microcapsule wall is formed of an encapsulating polymer that is an aggregate of a BPEI. In some embodiments, the aggregation consists essential of BPEI, e.g., by adjusting the pH of the BPEI solution so that it assembles into an aggregate to encapsulate the oil core.
In other embodiments, the aggregate is formed when an aggregate formation aid is added to BPEI to form the aggregate. In these embodiments, the aggregate contains BPEI and an aggregate formation aid. Suitable aggregate formation aids include water-soluble cations, water-soluble anions, and a transglutaminase. Preferred aggregate formation aids are the transglutaminase, multivalent water-soluble anions (e.g., sulfate, carbonate, and phosphate) and anionic polymers (such as an alginate, poly(styrene sulfonate), hyaluronic acid, poly(acrylic acid), carboxymethyl cellulose, gelatin, and combinations thereof).
Some of the above components are described in detail below.
Representative BPEI structure is shown below:
in which n is an integer from 1 to 20,000 (e.g., to 10,000, 2 to 5,000, and 2 to 1,000). BPEI for use in this invention preferably has a molecular weight of 500 to 5,000,000 Daltons (e.g., 500 to 1,000,000 Daltons, 750 to 500,000 Daltons, 750 to 100,000 Daltons, and 750 to 50,000 Daltons).
BPEI are commercially available from Sigma-Aldrich (St. Louis, Mo.; average molecular weight 25,000 Daltons) and Polysciences Inc. (Warrington, Pa.; various products having molecular weight from 600, 1200, 1800, 10,000, 70,000, 750,000, 250,000, and 2,000,000 Daltons).
Suitable polyfunctional amines include those described in WO 2015/023961. Examples are hexamethylenediamine, hexaethylenediamine, ethylenediamine, 1,3-diaminopropane, 1,4-diamino-butane, diethylenetriamine, pentaethylenehexamine, bis(3-aminopropyl)amine, bis(hexanethylene)triamine, tris(2-aminoethyl)amine, triethylene-tetramine, N,N′-bis(3-aminopropyl)-1,3-propanediamine, tetraethylenepentamine, amino-2-methyl-1-propanol, chitosan, 1,3-diamino-guanidine, 1,1-dimethylbiguanide, guanidine, arginine, lysine, histidine, ornithine, nisin, gelatin, and combinations thereof.
Suitable polyfunctional alcohols are also described in WO 2015/023961. Examples include pentaerythritol, dipentaerythritol, glycerol, polyglycerol, ethylene glycol, polyethylene glycol, trimethylolpropane, neopentyl glycol, sorbitol, erythritol, threitol, arabitol, xylitol, ribitol, mannitol, galactitol, fucitol, iditol, inositol, volemitol, isomalt, maltitol, lactitol, maltotriitol, maltotetraitol, polyglycitol, and combinations thereof.
The carbonyl crosslinkers each have at least two functional groups, e.g., a first functional group and a second functional group.
The first functional group is an electrophilic group reactive towards the branched polyethyleneimine, the polyfunctional amine, or the polyfunctional alcohol to form a network of the encapsulating polymer. Examples include formyl, keto, carboxyl, a carboxylate ester group, an acyl halide group, an amide group, a carboxylic anhydride group, an alkyl halide group, an epoxide group, an aziridine group, an oxetane group, an azetidine group, a sulfonyl halide group, a chlorophosphate group, an isocyanate group, an α,β-unsaturated carbonyl group, an α,β-unsaturated nitrile group, or an α,β-unsaturated methanesulfonyl group. Preferably, the first function group is a carbonyl electrophilic group containing a carbonyl group such as formyl, keto, carboxyl, a carboxylate ester group, an acyl halide group, an amide group, a carboxylic anhydride group, an α,β-unsaturated carbonyl group, a trifluoromethanesulfonate group, and a p-toluenesulfonate group.
The second functional group is an electrophilic group reactive towards the branched polyethyleneimine, the polyfunctional amine, or the polyfunctional alcohol. It can be selected from the groups listed immediately above.
Examples of a carbonyl crosslinker include glutaric dialdehyde, succinic dialdehyde, and glyoxal; as well as compounds such as glyoxyl trimer and paraformaldehyde, bis(dimethyl) acetal, bis(diethyl) acetal, polymeric dialdehydes, such as oxidized starch. Preferably the cross-linking agent is a low molecular weight, difunctional aldehyde, such as glyoxal, malonaldehyde, succinaldehyde, glutaraldehyde, adipaldehyde, starch aldehyde, and combinations thereof.
Some crosslinking reactions between the BPEI and the carbonyl crosslinker are shown below:
In the scheme above, R—NH2 is BPEI, and the other reactant is the carbonyl crosslinker. In some of the above reactions, a C═N double bond is formed, which can be reduced to a more stable C—N single bond by a reducing agent, e.g., sodium borohydride.
More examples of the crosslinking reactions are shown below:
The encapsulating polymer can be a reaction product between BPEI (or its mixture) and a mixture of a carbonyl crosslinker and a polyisocyanate.
These polyisocyanates each contain two or more isocyanate (—NCO) groups. Suitable polyisocyanates include, for example, 1,5-naphthylene diisocyanate, 4,4′-diphenylmethane diisocyanate (MDI), hydrogenated MDI (H12MDI), xylylene diisocyanate (XDI), tetramethylxylol diisocyanate (TMXDI), 4,4′-diphenyldimethylmethane diisocyanate, di- and tetraalkyldiphenylmethane diisocyanate, 4,4′-dibenzyl diisocyanate, 1,3-phenylene diisocyanate, 1,4-phenylene diisocyanate, the isomers of tolylene diisocyanate (TDI), optionally in a mixture, 1-methyl-2,4-diisocyanatocyclohexane, 1,6-diisocyanato-2,2,4-trimethylhexane, 1,6-diisocyanato-2,4,4-trimethylhexane, 1-isocyanatomethyl-3-isocyanato-1,5,5-trimethylcyclohexane, chlorinated and brominated diisocyanates, phosphorus-containing diisocyanates, 4,4′-diisocyanatophenylperfluoroethane, tetramethoxybutane 1,4-diisocyanate, butane 1,4-diisocyanate, hexane 1,6-diisocyanate (HDI), dicyclohexylmethane diisocyanate, cyclohexane 1,4-diisocyanate, ethylene diisocyanate, phthalic acid bisisocyanatoethyl ester, also polyisocyanates with reactive halogen atoms, such as 1-chloromethylphenyl 2,4-diisocyanate, 1-bromomethylphenyl 2,6-diisocyanate, and 3,3-bischloromethyl ether 4,4′-diphenyldiisocyanate. Sulfur-containing polyisocyanates are obtained, for example, by reacting hexamethylene diisocyanate with thiodiglycol or dihydroxydihexyl sulfide. Further suitable diisocyanates are trimethylhexamethylene diisocyanate, 1,4-diisocyanatobutane, 1,2-diisocyanatododecane, dimer fatty acid diisocyanate, and combinations thereof.
Other suitable commercially-available polyisocyanates include LUPRANATE M20 (PMDI, commercially available from BASF containing isocyanate group “NCO” 31.5 wt %), where the average n is 2.7; PAPI 27 (PMDI commercially available from Dow Chemical having an average molecular weight of 340 and containing NCO 31.4 wt %) where the average n is 2.7; MONDUR MR (PMDI containing NCO at 31 wt % or greater, commercially available from Bayer) where the average n is 2.8; MONDUR MR Light (PMDI containing NCO 31.8 wt %, commercially available from Bayer) where the average n is 2.8; MONDUR 489 (PMDI commercially available from Bayer containing NCO 30-31.4 wt %) where the average n is 3; poly[(phenylisocyanate)-co-formaldehyde] (Aldrich Chemical, Milwaukee, Wis.), other isocyanate monomers such as DESMODUR N3200 (poly(hexamethylene diisocyanate) commercially available from Bayer), and TAKENATE D110-N (xylene diisocyanate adduct polymer commercially available from Mitsui Chemicals corporation, Rye Brook, N.Y., containing NCO 11.5 wt %), DESMODUR L75 (a polyisocyanate base on toluene diisocyanate commercially available from Bayer), and DESMODUR IL (a polyisocyanate based on toluene diisocyanate commercially available from Bayer).
In some embodiments, the polyisocyanate used in the preparation of the capsules of this invention is a single polyisocyanate. In other embodiments the polyisocyanate is a mixture of polyisocyanates. In some embodiments, the mixture of polyisocyanates includes an aliphatic polyisocyanate and an aromatic polyisocyanate. In particular embodiments, the mixture of polyisocyanates is a biuret of hexamethylene diisocyanate and a trimethylol propane-adduct of xylylene diisocyanate. In certain embodiments, the polyisocyanate is an aliphatic isocyanate or a mixture of aliphatic isocyanate, free of any aromatic isocyanate. In other words, in these embodiments, no aromatic isocyanate is used to prepare the polyurea/polyurethane polymers as capsule wall materials.
The average molecular weight of certain suitable polyisocyanates varies from 250 to 1000 Da and preferable from 275 to 500 Da. In general, the range of the polyisocyanate concentration varies from 0.1% to 10%, preferably from 0.1% to 8%, more preferably from 0.2 to 5%, and even more preferably from 1.5% to 3.5%, all based on the weight of the microcapsule composition.
More examples of suitable polyisocyanates can be found in WO 2004/054362; WO 2015/023961; EP 0 148149; EP 0 017 409 B1; U.S. Pat. No. 4,417,916, U.S. Pat. No. 4,124,526, U.S. Pat. No. 5,583,090, U.S. Pat. No. 6,566,306, U.S. Pat. No. 6,730,635, PCT 90/08468, PCT WO 92/13450, U.S. Pat. No. 4,681,806, U.S. Pat. No. 4,285,720 and U.S. Pat. No. 6,340,653.
The Encapsulating polymer can also include one or more additional wall polymers, e.g., a second, third, fourth, fifth, or sixth polymer. These additional polymers can be selected from the group consisting of silica, polyacrylate, polyacrylamide, poly(acrylate-co-acrylamide), polyurea, polyurethane, starch, gelatin and gum Arabic, poly(melamine-formaldehyde), poly(urea-formaldehyde), and combinations thereof.
Conventional encapsulation methods can be used to prepare the BPEI microcapsules. See WO 2015/023961. In some embodiments, capsule formation aids, e.g., a surfactant or dispersant, are used.
By way of illustration, to prepare a BPEI microcapsule having a crosslinked encapsulating polymer, an oil-in-water emulsion is first prepared containing (i) BPEI or its mixture, (ii) a carbonyl crosslinker or its mixture, (iii) an oil phase having an active material, and (iv) an aqueous phase having a microcapsule formation aid and water. The reaction between BPEI (or its mixture) and the carbonyl crosslinker (or its mixture) occurs when the temperature of the reaction mixture is raised or a catalyst (such as a transglutaminase for catalyzing amide formation) is added to the mixture.
Catalysts suitable for use in the invention are transglutaminases, metal carbonates, metal hydroxide, amino or organometallic compounds and include, for example, sodium carbonate, cesium carbonate, potassium carbonate, lithium hydroxide, 1,4-diazabicyclo[2.2.2]octane (i.e., DABCO), N,N-dimethylaminoethanol, N,N-dimethylcyclohexylamine, bis-(2-dimethylamino-ethyl) ether, N,N dimethylacetylamine, stannous octoate and dibutyltin dilaurate.
The resultant microcapsule slurry is then cured at a predetermined temperature for a predetermined period of time.
To prepare a BPEI microcapsule having an aggregate of BPEI, an oil-in-water emulsion is first prepared by emulsifying (i) a branched polyethyleneimine, (ii) an oil phase having an active material, and (iii) an aqueous phase having a microcapsule formation aid and water. The aggregate is then formed by adjusting the pH of the emulsion, raising the temperature of the emulsion, or adding an aggregate formation aid to the emulsion. The resultant microcapsule slurry is then cured to make the BPEI microcapsule having the BPEI aggregate.
In accordance with some embodiments of this invention, the microcapsules prepared according to the methods above are cured at a temperature in the range of, e.g., 15° C. to 230° C. (e.g., 55° C. to 90° C., 55° C. to 75° C., and 90° C. to 130° C.) for 1 minute to 10 hours (e.g., 0.1 hours to 5 hours, 0.2 hours to 4 hours and 0.5 hours to 3 hours). A skilled person in the art can determine, without undue experiments, the curing temperature, duration, and the heating rate.
To obtain microcapsules with more leaching of the active material, certain embodiments of this invention provide for a cure at a low temperature, e.g., less than 100° C. In some embodiments, the cure temperature is at or less than 90° C. In other embodiments, the cure temperature is at or less than 80° C. In one embodiment, the capsules are heated to a target cure temperature at a linear rate of 0.5 to 2° C. per minute (e.g., 1 to 5° C. per minute, 2 to 8° C. per minute, and 2 to 10° C. per minute) over a period of 1 to 60 minutes (e.g., 1 to 30 minutes). The following heating methods may be used: conduction for example via oil, steam radiation via infrared, and microwave, convection via heated air, steam injection and other methods known by those skilled in the art. The target cure temperature used herein refers to the minimum temperature in degrees Celsius at which the capsules may be cured to retard leaching.
Most microcapsule formation aids are used as dispersants (namely, emulsifiers or surfactants). They facilitate the formation of stable emulsions containing nano- or micro-sized oil drops to be encapsulated. Further, microcapsule formation aids improve the performance of the microcapsule by stabilizing capsules and/or their deposition to the target areas or releasing to the environment. Performance is measured by the intensity of the fragrance release during the use experience, such as the pre-rub and post-rub phases in a laundry experience. The pre-rub phase is the phase when the microcapsules have been deposited on the cloth, e.g., after a fabric softener containing microcapsules has been used during the wash cycle. The post-rub phase is after the microcapsules have been deposited and the microcapsules are broken by friction or other similar mechanisms.
The amount of these microcapsule formation aids is anywhere from about 0.1 to about 40 percent by weight of the microcapsule, more preferably from 0.5 to about 10 percent, more preferably 0.5 to 5 percent by weigh.
Preferred microcapsule formation aids are polyvinyl pyrrolidone, polyvinyl alcohol, poly(styrene sulfonate), carboxymethyl cellulose, sodium salt of naphthalene sulfonate condensate, co-polymer of ethylene and maleic anhydride, an alginate, hyaluronic acid, poly(acrylic acid), carboxymethyl cellulose, copolymers of acrylic acid and acrylamide, copolymer of acrylamide and acrylamidopropyltrimonium chloride, terpolymers of (acrylic acid, acrylamide, and acrylamidopropyltrimonium chloride), partially or completely hydrolyzed polyvinyl acetate polymers (i.e., polyvinyl alcohol), and combinations thereof.
Other microcapsule formation aids include water-soluble salts of alkyl sulfates, alkyl ether sulfates, alkyl isothionates, alkyl carboxylates, alkyl sulfosuccinates, alkyl succinamates, alkyl sulfate salts such as sodium dodecyl sulfate, alkyl sarcosinates, alkyl derivatives of protein hydrolyzates, acyl aspartates, alkyl or alkyl ether or alkylaryl ether phosphate esters, sodium dodecyl sulphate, phospholipids or lecithin, or soaps, sodium, potassium or ammonium stearate, oleate or palmitate, alkylarylsulfonic acid salts such as sodium dodecylbenzenesulfonate, sodium dialkylsulfosuccinates, dioctyl sulfosuccinate, sodium dilaurylsulfosuccinate, poly(styrene sulfonate) sodium salt, isobutylene-maleic anhydride copolymer, gum arabic, sodium alginate, cellulose sulfate and pectin, isobutylene-maleic anhydride copolymer, gum arabic, carrageenan, sodium alginate, pectic acid, tragacanth gum, almond gum and agar; semi-synthetic polymers such as sulfated cellulose, sulfated methylcellulose, carboxymethyl starch, phosphated starch, lignin sulfonic acid; and synthetic polymers such as maleic anhydride copolymers (including hydrolyzates thereof), polyacrylic acid, polymethacrylic acid, acrylic acid butyl acrylate copolymer or crotonic acid homopolymers and copolymers, vinylbenzenesulfonic acid or 2-acrylamido-2-methylpropanesulfonic acid homopolymers and copolymers, and partial amide or partial ester of such polymers and copolymers, carboxy modified polyvinyl alcohol, sulfonic acid-modified polyvinyl alcohol and phosphoric acid-modified polyvinyl alcohol, phosphated or sulfated tristyrylphenol ethoxylates.
Commercially available surfactants include, but are not limited to, sulfonated naphthalene-formaldehyde condensates such as MORWET D425 (naphthalene sulfonate, Akzo Nobel, Fort Worth, Tex.); partially hydrolyzed polyvinyl alcohols such as MOWIOLs, e.g., MOWIOL 3-83 (Air Products); ethylene oxide-propylene oxide block copolymers or poloxamers such as PLURONIC, SYNPERONIC or PLURACARE materials (BASF); sulfonated polystyrenes such as FLEXAN II (Akzo Nobel); ethylene-maleic anhydride polymers such as ZEMAC (Vertellus Specialties Inc.); copolymer of acrylamide and acrylamidopropyltrimonium chloride such as Salcare SC 60 (BASF); and Polyquaternium series such as Polyquaternium 11 (“PQ11;” a copolymer of vinyl pyrrolidone and quaternized dimethylaminoethyl methacrylate; sold by BASF as LUVIQUAT PQ11 AT 1).
In other embodiments, the capsule formation aid is a processing aid such as hydrocolloids, which improve the colloidal stability of the slurry against coagulation, sedimentation and creaming. The term “hydrocolloid” refers to a broad class of water-soluble or water-dispersible polymers having anionic, cationic, zwitterionic or non-ionic character. Hydrocolloids useful in the present invention include, but are not limited to, polycarbohydrates, such as starch, modified starch, dextrin, maltodextrin, and cellulose derivatives, and their quaternized forms; natural gums such as alginate esters, carrageenan, xanthanes, agar-agar, pectins, pectic acid, and natural gums such as gum arabic, gum tragacanth and gum karaya, guar gums and quaternized guar gums; gelatine, protein hydrolysates and their quaternized forms; synthetic polymers and copolymers, such as poly(vinyl pyrrolidone-co-vinyl acetate), poly(vinyl alcohol-co-vinyl acetate), poly((met)acrylic acid), poly(maleic acid), poly(alkyl(meth)acrylate-co-(meth)acrylic acid), poly(acrylic acid-co-maleic acid)copolymer, poly(alkyleneoxide), poly(vinylmethylether), poly(vinylether-co-maleic anhydride), and the like, as well as poly-(ethyleneimine), poly((meth)acrylamide), poly(alkyleneoxide-co-dimethylsiloxane), poly(amino dimethylsiloxane), and the like, and their quaternized forms.
The capsule formation aid may also be used in combination with carboxymethyl cellulose (“CMC”), polyvinylpyrrolidone, polyvinyl alcohol, alkylnaphthalenesulfonate formaldehyde condensates, and/or a surfactant during processing to facilitate capsule formation. Examples of surfactants that can be used in combination with the capsule formation aid include, but are not limited to, cetyl trimethyl ammonium chloride (CTAC), poloxamers such as PLURONICS (e.g., PLURONIC F127), PLURAFAC (e.g., PLURAFAC F127), or MIRANET-N, saponins such as QNATURALE (National Starch Food Innovation); or a gum Arabic such as Seyal or Senegal. In certain embodiments, the CMC polymer has a molecular weight range between about 90,000 Daltons to 1,500,000 Daltons, preferably between about 250,000 Daltons to 750,000 Daltons and more preferably between 400,000 Daltons to 750,000 Daltons. The CMC polymer has a degree of substitution between about 0.1 to about 3, preferably between about 0.65 to about 1.4, and more preferably between about 0.8 to about 1.0. The CMC polymer is present in the capsule slurry at a level from about 0.1% to about 2% and preferably from about 0.3% to about 0.7%. in other embodiments, polyvinylpyrrolidone used in this invention is a water-soluble polymer and has a molecular weight of 1,000 to 10,000,000. Suitable polyvinylpyrrolidone are polyvinylpyrrolidone K12, K15, K17, K25, K30, K60, K90, or a mixture thereof. The amount of polyvinylpyrrolidone is 2-50%, 5-30%, or 10-25% by weight of the capsule delivery system. Commercially available alkylnaphthalenesulfonate formaldehyde condensates include MORWET D-425, which is a sodium salt of naphthalene sulfonate condensate by Akzo Nobel, Fort Worth, Tex.
The microcapsule compositions containing one of the BPEI microcapsules described above can also include one or more additional delivery systems.
In some embodiments, the microcapsule composition of this invention contains a BPEI microcapsule and one or more additional non-BPEI microcapsules. These microcapsules are free of BPEI. Wall forming materials include melamine formaldehyde, polyurethane, polysiloxanes, polyurea, polyamide, polyimide, polyvinyl alcohol, polyanhydride, polyolefin, polysulfone, polysaccharide, protein, polylactide (PLA), polyglycolide (PGA), polyorthoester, polyphosphazene, silicone, lipid, modified cellulose, gums, polystyrene, and polyesters or combinations of these materials. Other polymeric materials that are functional are ethylene maleic anhydride copolymer, styrene maleic anhydride copolymer, ethylene vinyl acetate copolymer, and lactide glycolide copolymer. Biopolymers that are derived from alginate, chitosan, collagen, dextran, gelatin, and starch can also be used as the encapsulating materials. Additionally, capsules can be made via the simple or complex coacervation of gelatin. Preferred encapsulating wall polymers include those formed from isocyanates, acrylates, acrylamide, acrylate-co-acrylamide, hydrogel monomers, sol-gel precursors, gelatin, melamine-formaldehyde or urea-formaldehyde condensates, as well as similar types of aminoplasts.
Preferred additional non-BPEI microcapsules are aminoplasts and gelatin capsules, urea-formaldehyde and melamine-formaldehyde capsules, and polyurea/polyurethane microcapsules. See US 2007/0078071, U.S. Pat. No. 6,261,483, and U.S. Pat. No. 8,299,011.
The core of the capsules of the invention can include one or more active materials including, but not limited to, flavors and/or fragrance ingredients such as fragrance oils. Nonlimiting examples include those described in WO 2016/049456. These active material include flavor or fragrance ingredients, taste masking agents, taste sensates, malodor counteracting agents, vitamins, antibacterials, sunscreen actives, antioxidants, anti-inflammatory agents, anesthetics, analgesics, antifungal agents, antibiotics, anti-viral agents, anti-parasitic agents, anti-infectious and anti-acne agents, dermatological active ingredients, enzymes and co-enzymes, skin whitening agents, anti-histamines, chemotherapeutic agents, and insect repellents. In addition to the active materials listed above, the products of this invention can also contain dyes, colorants or pigments, naturally obtained extracts (for example paprika extract and black carrot extract), and aluminum lakes.
In some embodiments, the amount of encapsulated active material is from 5 to 95% (e.g., 20 to 90% and 40 to 85%) by weight of the capsule. The amount of the capsule wall is from 0.5% to 25% (e.g., 1.5 to 15% and 2.5 to 10%) also by weight of the capsule. In other embodiments, the amount of the encapsulated active material is from 15% to 99.5% (e.g., 50 to 98% and 30 to 95%) by weight of the capsule, and the amount of the capsule wall is from 0.5% to 85% (e.g., 2 to 50% and 5 to 70%) by weight of the capsule.
In addition to the active materials, the present invention also contemplates the incorporation of adjunct materials including solvent, emollients, and core modifier materials in the core encapsulated by the capsule wall. Other adjunct materials are nanoscale solid particulate materials, polymeric core modifiers, solubility modifiers, density modifiers, stabilizers, humectants, viscosity modifiers, pH modifiers, or any combination thereof. These modifiers can be present in the wall or core of the capsules, or outside the capsules in delivery system. Preferably, they are in the core as a core modifier.
The one or more adjunct material may be added in the amount of from 0.01% to 25% (e.g., from 0.5% to 10%) by weight of the capsule.
Suitable examples include those described in WO 2016/049456 and US 2016/0158121.
A capsule deposition aid from 0.01 to 25%, more preferably from 5 to 20% can be included by weight of the capsule. The capsule deposition aid can be added during the preparation of the capsules or it can be added after the capsules have been made.
These deposition aids are used to aid in deposition of capsules to surfaces such as fabric, hair or skin. These include anionic, cationic, nonionic, or amphoteric water-soluble polymers. Suitable deposition aids include polyquaternium-4, polyquaternium-5, polyquaternium-6, polyquaternium-7, polyquaternium-10, polyquaternium-16, polyquaternium-22, polyquaternium-24, polyquaternium-28, polyquaternium-39, polyquaternium-44, polyquaternium-46, polyquaternium-47, polyquaternium-53, polyquaternium-55, polyquaternium-67, polyquaternium-68, polyquaternium-69, polyquaternium-73, polyquaternium-74, polyquaternium-77, polyquaternium-78, polyquaternium-79, polyquaternium-80, polyquaternium-81, polyquaternium-82, polyquaternium-86, polyquaternium-88, polyquaternium-101, polyvinylamine, polyethyleneimine, polyvinylamine and vinylformamide copolymer, an acrylamidopropyltrimonium chloride/acrylamide copolymer, a methacrylamidopropyltrimonium chloride/acrylamide copolymer, and combinations thereof. Other suitable deposition aids include those described in WO 2016049456, pages 13-27. Additional deposition aids are described in US 2013/0330292, US 2013/0337023, and US 2014/0017278.
The reloadable microcapsule can be formulated into a capsule delivery system (e.g., a microcapsule composition) for use in consumer products.
The capsule delivery system can be a slurry containing in an external hydrophilic solvent (e.g., water, ethanol, and a combination thereof) the capsule at a level 0.1 to 80% (e.g., 70-75%, 40-55%, 50-90%, 1 to 65%, and 5 to 45%) by weight of the capsule delivery system.
In some embodiments, the capsule and its slurry prepared in accordance with the present invention is subsequently purified. See US 2014/0017287. Purification can be achieved by washing the capsule slurry with water until a neutral pH is achieved.
The delivery system can also be spray dried to a solid form. In a spray drying process, a spray dry carrier is added to a capsule delivery system to assist the removal of water from the slurry. See WO 2016/144798.
The capsule delivery system can also be sprayed as a slurry onto a consumer product, e.g., a fabric care product. By way of illustration, a liquid delivery system containing capsules is sprayed onto a detergent powder during blending to make granules. See US 2011/0190191. In order to increase fragrance load, water-absorbing material, such as zeolite, can be added to the delivery system.
Alternatively, granulates in a consumer product are prepared in a mechanical granulator in the presence of a granulation auxiliary such as non-acid water-soluble organic crystalline solids. See WO 2005/097962.
(iii) Additional components. The capsule delivery system can include one or more non-confined, unencapsulated active materials from about 0.01% to about 50%, more preferably from about 5% to about 40%.
The capsule delivery system can also contain one or more other delivery system such as polymer-assisted delivery compositions (see U.S. Pat. No. 8,187,580), fiber-assisted delivery compositions (US 2010/0305021), cyclodextrin host guest complexes (U.S. Pat. No. 6,287,603 and US 2002/0019369), pro-fragrances (WO 2000/072816 and EP 0 922 084), and any combination thereof. The capsule delivery system can also contain one or more (e.g., two, three, four, five or six more) different capsules including different capsules of this invention and other capsules such as aminoplasts, hydrogel, sol-gel, coacervate capsules, polyurea/polyurethane capsules, and melamine formaldehyde capsules. More exemplary delivery systems that can be incorporated are coacervate capsules, cyclodextrin delivery systems, and spray dry encapsulation. See WO 2016/144798.
Any compound, polymer, or agent discussed above can be the compound, polymer, or agent itself as shown above, or its salt, precursor, hydrate, or solvate. A salt can be formed between an anion and a positively charged group on the compound, polymer, or agent. Suitable anions include chloride, bromide, iodide, sulfate, nitrate, phosphate, citrate, methanesulfonate, trifluoroacetate, acetate, malate, tosylate, tartrate, fumarate, glutamate, glucuronate, lactate, glutarate, and maleate. Likewise, a salt can also be formed between a cation and a negatively charged group on the compound, polymer, or agent. Suitable cations include sodium ion, potassium ion, magnesium ion, calcium ion, and an ammonium cation (e.g., tetramethylammonium ion). A precursor can be ester and another suitable derivative, which, during the process of preparing a polyurea or polyurethane capsule composition of this invention, is capable of converting to the compound, polymer, or agent and being used in preparing the polyurea or polyurethane capsule composition. A hydrate refers to the compound, polymer, or agent that contains water. A solvate refers to a complex formed between the compound, polymer, or agent and a suitable solvent. A suitable solvent can be water, ethanol, isopropanol, ethyl acetate, acetic acid, and ethanolamine.
Certain compounds, polymers, and agents have one or more stereocenters, each of which can be in the R configuration, the S configuration, or a mixture. Further, some compounds, polymers, and agents possess one or more double bonds wherein each double bond exists in the E (trans) or Z (cis) configuration, or combinations thereof. The compounds, polymers, and agents include all possible configurational stereoisomeric, regioisomeric, diastereomeric, enantiomeric, and epimeric forms as well as any mixtures thereof. As such, lysine used herein includes L-lysine, D-lysine, L-lysine monohydrochloride, D-lysine monohydrochloride, lysine carbonate, and so on. Similarly, arginine includes L-arginine, D-arginine, L-arginine monohydrochloride, D-arginine monohydrochloride, arginine carbonate, arginine monohydrate, and etc. Guanidine includes guanidine hydrochloride, guanidine carbonate, guanidine thiocyanate, and other guanidine salts including their hydrates. Ornithine includes L-ornithine and its salts/hydrates (e.g., monohydrochloride) and D-ornithine and its salts/hydrates (e.g., monohydrochloride).
Applications. The delivery systems of the present invention are well-suited for use, without limitation, in the following products:
The above-listed applications are all well known in the art. For example, fabric softener systems are described in U.S. Pat. Nos. 6,335,315 and 5,674,832. Liquid laundry detergents include those systems described in U.S. Pat. Nos. 5,929,022 and 5,916,862. Liquid dish detergents are described in U.S. Pat. Nos. 6,069,122 and 5,990,065. Shampoo and conditioners that can employ the present invention include those described in U.S. Pat. Nos. 6,162,423 and 5,968,286. Automatic Dish Detergents are described in U.S. Pat. Nos. 6,020,294 and 6,017,871.
The invention is described in greater detail by the following non-limiting examples. Without further elaboration, it is believed that one skilled in the art can, based on the description herein, utilize the present invention to its fullest extent. All publications cited herein are incorporated by reference in their entirety.
A BPEI microcapsule composition, Composition 1, was prepared by crosslinking BPEI and glutaraldehyde, a dialdehyde having the formula CH2(CH2CHO)2.
First, an oil phase was prepared by mixing 96 grams of fragrance oil and 24 grams of Neobee oil. An aqueous phase was prepared in a separate container by mixing 15 grams of polyvinyl pyrrolidone and 60 grams of Luviquat® PQ 11 (polyquaternium-11) in 41.4 grams of water. The water phase was then added to the oil phase. The resultant mixture was homogenized at 12500 RPM for 2 min and continuously mixed with an overhead stirrer for 2 minutes to obtain an oil-in-water emulsion, to which 25.2 grams of 3% BPEI solution in water was slowly added, followed by the addition of 38.4 grams of 2.5% glutaraldehyde. Subsequently, the mixture was stirred for 30 minutes to allow the formation of a microcapsule precursor. Curing at 55° C. for 4 to 5 hours gave Microcapsule 1.
Microcapsule 1 was observed by optical microscopy. The particle sizes of the microcapsules were measured and found to be in the range of 0.5 to 80 μm.
A second microcapsule composition, i.e., Composition 2, was prepared by coacervate BPEI into an aggregate to encapsulate a fragrance oil.
Thirty three grams of a fragrance, i.e., Eden AI (commercially available from International Flavors and Fragrance, Union Beach, N.J.) was weighed out as an oil phase. In a separate beaker, an aqueous solution (57 grams) containing 1 8% of FLEXAN II (Akzo Nobel, Bridgewater, N.J.) was mixed with a solution (10 grams) of 1% CMC in water to obtain an aqueous phase. The oil phase was then emulsified into the aqueous phase to form an oil-in-water emulsion under shearing (ULTRA TURRAX, T25 Basic, IKA WERKE) at 6500 rpm for two minutes.
Subsequently, a 5.6 mL aqueous solution with 18 wt % poly(Poly(4-styrenesulfonic acid) (PSS, molecular weight of 75,000 g/mol) was slowly added into the emulsion under agitation. After 30 minutes, 3.3 mL of 30% branched polyethyleneimine (BPEI, Sigma-Aldrich, St. Louis, Mo.) was added and stirred for 30 minutes. Then, 5 mL of 20% Gelatin (Sigma-Aldrich, St. Louis, Mo.) was added under constant mixing with an overhead mixer. This cycle of adding the PSS solution, the BPEI solution, and then gelatin solution was repeated five times to obtain a BPEI microcapsule having 5 layers of PSS-BPEI-gelatin aggregate that encapsulating a fragrance oil core.
All of the features disclosed in this specification may be combined in any combination. Each feature disclosed in this specification may be replaced by an alternative feature serving the same, equivalent, or similar purpose. Thus, unless expressly stated otherwise, each feature disclosed is only an example of a generic series of equivalent or similar features.
Indeed, to achieve the purpose of preparing a BPEI microcapsule and a composition containing the microcapsule, one skilled in the art can choose different crosslinkers, additional wall polymer precursors, and/or capsule formation aids/catalysts, varying the concentrations of these wall-forming materials and/or catalysts to achieve desirable organoleptic or release profiles in a consumer product. Further, the ratios among their wall-forming materials, capsule forming aids, adjuvants, core modifiers, active materials, and catalysts can also be determined by a skilled artisan without undue experimentation.
From the above description, a skilled artisan can easily ascertain the essential characteristics of the present invention, and without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions. Thus, other embodiments are also within the claims.
